Stock data
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA) reported revenue of US$216.10M and net income of -US$220.47M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$216.10M | — | -US$151.17M | -US$220.47M | — |
| 2024 | US$198.77M | — | -US$40.66M | -US$18.90M | — |
| 2023 | US$192.64M | — | -US$13.95M | US$2.51M | — |
| 2022 | US$254.38M | — | US$6.33M | US$6.28M | — |
| 2021 | US$268.68M | — | US$42.16M | US$33.15M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$50.53M | -US$62.51M | — |
| 2026-03-31 | US$51.72M | -US$48.57M | — |
| 2025-12-31 | US$57.22M | -US$141.19M | — |
| 2025-09-30 | US$56.26M | -US$22.59M | — |
| 2025-06-30 | US$52.59M | -US$27.21M | — |
| 2025-03-31 | US$50.04M | -US$29.49M | — |
| 2024-12-31 | US$53.19M | -US$4.91M | — |
| 2024-09-30 | US$47.65M | -US$5.32M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.